Subscribe
ericsphotography-istockphoto-com-us-gavel-2-1
ericsphotography / iStockphoto.com
26 March 2018Americas

Indivior pledges to appeal generic Suboxone decision

UK-based Indivior has pledged to appeal a US court decision that found a drug developed by generics maker Alvogen doesn’t infringe three of Indivior’s patents.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
Indivior settles addiction drug dispute with Par
16 May 2018   Addiction drug producer Indivior has settled its patent infringement dispute with generics manufacturer Par Pharmaceutical.
Americas
Indivior obtains court order to block generic Suboxone
18 June 2018   Addiction treatment drug producer Indivior has obtained a temporary restraining order against Indian generic maker Dr Reddy’s, blocking the company from launching a generic version of Suboxone (buprenorphine and naloxone) Film.
Americas
US judge invalidates Pernix patents in Alvogen clash
28 August 2018   Generics maker Alvogen secured a patent win at a US court last week, despite the judge finding that the company had infringed patents covering an opioid treatment.


Editor's picks

Europe
UPC confirms validity of Edwards Lifesciences heart valve tech patent
23 July 2024

Editor's picks

Europe
UPC confirms validity of Edwards Lifesciences heart valve tech patent
23 July 2024
Americas
New-look WIPR Leaders 2024 is ‘most rigorous’ yet
2 July 2024
Americas
Earthquake Chevron: A massive shock to the system?
2 July 2024
Americas
Amarin wins appeal to advance ‘skinny label’ suit over Hikma generic
27 June 2024
Biotechnology
Guardant Health files suit against Tempus AI
13 June 2024
Big Pharma
Roche fires lawsuit at Sinocare unit over blood glucose test strip patents
6 June 2024

More on this story

Americas
Indivior settles addiction drug dispute with Par
16 May 2018   Addiction drug producer Indivior has settled its patent infringement dispute with generics manufacturer Par Pharmaceutical.
Americas
Indivior obtains court order to block generic Suboxone
18 June 2018   Addiction treatment drug producer Indivior has obtained a temporary restraining order against Indian generic maker Dr Reddy’s, blocking the company from launching a generic version of Suboxone (buprenorphine and naloxone) Film.
Americas
US judge invalidates Pernix patents in Alvogen clash
28 August 2018   Generics maker Alvogen secured a patent win at a US court last week, despite the judge finding that the company had infringed patents covering an opioid treatment.

More on this story

Americas
Indivior settles addiction drug dispute with Par
16 May 2018   Addiction drug producer Indivior has settled its patent infringement dispute with generics manufacturer Par Pharmaceutical.
Americas
Indivior obtains court order to block generic Suboxone
18 June 2018   Addiction treatment drug producer Indivior has obtained a temporary restraining order against Indian generic maker Dr Reddy’s, blocking the company from launching a generic version of Suboxone (buprenorphine and naloxone) Film.
Americas
US judge invalidates Pernix patents in Alvogen clash
28 August 2018   Generics maker Alvogen secured a patent win at a US court last week, despite the judge finding that the company had infringed patents covering an opioid treatment.

More features

Chinese biotech takes out US rival’s nucleic acid patent at PTAB
Lewis Roca promotes tech expert to managing partner
Panitch Schwarze brings in molecular biologist
US targets ‘product hopping’ with biologic litigation curbs
UPC confirms validity of Edwards Lifesciences heart valve tech patent
ITC concludes row over biotech lab equipment between US and German rivals
UKIPO launches ‘revolutionary’ patent filing and AI tool
USPTO clarifies AI's role in patent eligibility